The Comparative Evaluation of the Therapeutic Effects of Autologous Cytokine-Rich Serum and Platelet-Rich Plasma in an Experimental Endometriosis Model

In: Research Square · 2025 · doi:10.21203/rs.3.rs-6874729/v1 · W4412753766
preprint OA: green CC0
📄 Open PDF View on OpenAlex View at publisher
AI-generated summary by claude@2026-06+body, 2026-06-08

Autologous cytokine-rich serum (ACRS) and platelet-rich plasma (PRP) both reduced endometriotic lesion scores, with ACRS showing superior anti-inflammatory effects but higher angiogenesis and fibrosis markers compared to PRP.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-08

This preprint compares Autologous Cytokine-Rich Serum (ACRS) and Platelet-Rich Plasma (PRP) as autologous intraabdominal treatments in a surgically induced rat model of endometriosis, evaluating inflammation, angiogenesis, and myofibroblast activity. Thirty-six adult female Wistar Albino rats were assigned to groups receiving endometriosis plus either ACRS or PRP (or distilled water), and lesion tissues were excised for histopathological scoring and immunohistochemistry for TNF-α, IL-6, VEGFA, and α-SMA. Both ACRS and PRP significantly reduced histopathological scores versus the endometriosis-only group; ACRS produced greater reductions in TNF-α and IL-6, while also showing higher VEGFA and α-SMA expression than PRP, suggesting relatively stronger angiogenic and fibrotic responses. A major caveat is that this is an unreviewed preprint, and findings come from an experimental rat model rather than human outcomes. This paper is centrally about endometriosis — it tests ACRS versus PRP in an experimental endometriosis model and reports molecular and histopathological effects.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (19)

Source provenance

europepmc
last seen: 2026-06-15T06:13:43.845377+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK